Preferred Label : apixaban;
MeSH note : an antithrombotic agent;
CISMeF synonym : BMS 562247;
MeSH hyponym : BMS562247; BMS-562247; BMS-562247-01;
Is substance : O;
UNII : 3Z9Y7UWC1J;
InChIKey : QNZCBYKSOIHPEH-UHFFFAOYSA-N;
Origin ID : C522181;
UMLS CUI : C1831808;
ATC code(s)
- CISMeF manual mappings
- MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
https://ansm.sante.fr/tableau-marr/apixaban
2023
false
false
false
France
French
guidelines for drug use
risk management
apixaban
administration, oral
apixaban
continuity of patient care
hemorrhage
Drug-Related side effects and adverse reactions
patient education handout
---
https://www.has-sante.fr/jcms/p_3352188/fr/eliquis-apixaban-reevaluation-place-dans-la-strategie-et-population-cible-dans-tvp/ep-en-cas-de-cancer-actif
2022
France
evaluation of the transparency committee
apixaban
target population
neoplasms
health services needs and demand
neoplasm, malignant
cancer
apixaban
snacks
Cancer
---
https://www.ema.europa.eu/en/medicines/human/EPAR/apixaban-accord
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
apixaban
apixaban
Factor Xa Inhibitors
Factor Xa Inhibitors
drugs, generic
venous thromboembolism
postoperative complications
adult
arthroplasty, replacement, hip
arthroplasty, replacement, knee
pulmonary embolism
deep vein thrombosis
pulmonary embolism
deep vein thrombosis
atrial fibrillation
stroke
administration, oral
apixaban
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
venous thrombosis
venous thrombosis
pyrazoles
pyridones
pyrazoles
pyridones
---
https://www.has-sante.fr/jcms/p_3199558/fr/eliquis
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
apixaban
apixaban
stroke
insurance, health, reimbursement
embolism
apixaban
Factor Xa Inhibitors
Factor Xa Inhibitors
adult
atrial fibrillation
hemorrhage
pyrazoles
pyridones
pyrazoles
pyridones
---
https://pharmactuel.com/index.php/pharmactuel/article/view/1321
2020
Canada
journal article
chemotherapy
drug therapy
has patient
apixaban
Chemotherapy
patients
chemotherapy, nos
pyrazoles
pyridones
---
https://ansm.sante.fr/informations-de-securite/Anticoagulants-Oraux-Directs-AODs-apixaban-Eliquis-R-rivaroxaban-Xarelto-R-dabigatran-Pradaxa-R-et-edoxaban-Lixiana-R-Roteas-R-non-recommandes-chez-les-patients-presentant-un-Syndrome-des-Antiphospholipides-SAPL
2019
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
administration, oral
apixaban
Rivaroxaban
edoxaban
anticoagulants
Dabigatran
recurrence
risk
antiphospholipid syndrome
thrombosis
thrombosis
pyrazoles
pyridones
pyridines
thiazoles
---
https://www.has-sante.fr/portail/jcms/c_2826829/fr/eliquis
2018
false
false
false
false
France
French
evaluation of the transparency committee
apixaban
apixaban
pyrazoles
pyridones
---
https://www.has-sante.fr/portail/jcms/c_2851086/fr/les-anticoagulants-oraux
2018
false
false
false
France
French
guidelines for drug use
anticoagulants
anticoagulants
administration, oral
antivitamins K
antivitamins K
atrial fibrillation
drug overdose
apixaban
Dabigatran
antithrombins
Factor Xa Inhibitors
Rivaroxaban
edoxaban
Direct factor Xa inhibitors
direct thrombin inhibitors
pregnancy
patient compliance
continuity of patient care
hemorrhage
surgical procedures, operative
blood loss, surgical
hemorrhage
vitamin k antagonists
fluindione
acenocoumarol
warfarin
pyridines
thiazoles
phenindione
phenindione
indenes
4-hydroxycoumarins
vitamin K
vitamin K
indenes
4-hydroxycoumarins
vitamin K
pyrazoles
pyridones
---
http://kce.fgov.be/fr/publication/report/anticoagulation-et-fibrillation-auriculaire
2017
false
false
false
Belgium
French
anticoagulants
anticoagulants
atrial fibrillation
treatment outcome
stroke
continuity of patient care
Cost-Benefit analysis
medication adherence
risk assessment
hemorrhage
vitamin K
antivitamins K
Rivaroxaban
edoxaban
Dabigatran
apixaban
Factor Xa Inhibitors
antithrombins
belgium
technical report
drug information
comparative study
anticoagulants
economic evaluation
drug monitoring
new oral anticoagulant
indenes
4-hydroxycoumarins
pyridines
thiazoles
pyrazoles
pyridones
---
http://www.centreantipoisons.be/professionnels-de-la-sant/articles-pour-professionnels-de-la-sant/nouveaux-anticoagulants-par-voie
2016
false
false
false
Belgium
French
Dutch
practice guideline
administration, oral
Rivaroxaban
rivaroxaban
anticoagulants
apixaban
Factor Xa Inhibitors
hemorrhage
hemorrhage
hemorrhage
apixaban
dabigatran etexilate
Dabigatran
antithrombins
hospitalization
ambulatory care
pyrazoles
pyridones
---
https://www.revmed.ch/RMS/2016/RMS-N-542/Anticoagulants-oraux-directs-ACOD-une-aide-a-la-prescription-dans-la-pratique-quotidienne
2016
false
false
false
Switzerland
French
journal article
venous thromboembolism
antithrombins
administration, oral
atrial fibrillation
Evidence-Based medicine
guidelines for drug use
recurrence
venous thromboembolism
antithrombins
Direct factor Xa inhibitors
Factor Xa Inhibitors
Factor IIa
dabigatran etexilate
Dabigatran
Rivaroxaban
apixaban
edoxaban
drug interactions
continuity of patient care
clinical chemistry tests
kidney function tests
hemorrhage
surgical procedures, operative
heparin
antivitamins K
patient safety
factor IIa
prothrombin
pyrazoles
pyridones
pyridines
thiazoles
indenes
4-hydroxycoumarins
vitamin K
vitamin K
---
https://www.revmed.ch/RMS/2016/RMS-N-529/Anticoagulants-oraux-directs-quelques-considerations-pratiques
2016
false
false
false
Switzerland
French
journal article
administration, oral
anticoagulants
thromboembolism
thromboembolism
Direct factor Xa inhibitors
direct thrombin inhibitors
aged
neoplasms
liver cirrhosis
obesity
continuity of patient care
drug interactions
antidotes
stroke
treatment outcome
anticoagulants
Dabigatran
Rivaroxaban
apixaban
edoxaban
anticoagulants
Contraindications, Procedure
pyrazoles
pyridones
pyridines
thiazoles
Contraindications, Drug
---
https://minerva-ebp.be/FR/Analysis/451
2016
false
false
false
Belgium
French
french abstract
scientific and technical information
drug therapy, combination
apixaban
antivitamins K
hemorrhage
platelet aggregation inhibitors
pyrazoles
pyridones
indenes
4-hydroxycoumarins
---
https://minerva-ebp.be/fr/analyses-en-ligne/300
2015
false
true
false
minerva-ebm.be
Belgium
French
french abstract
scientific and technical information
hemorrhage
antivitamins K
apixaban
indenes
4-hydroxycoumarins
vitamin K
pyrazoles
pyridones
---
http://www.has-sante.fr/portail/jcms/c_2038860/fr/eliquis
http://www.has-sante.fr/portail/jcms/c_2038860/fr/eliquis-apixaban-anticoagulant-par-voie-orale
2015
false
France
French
recurrence
deep vein thrombosis
deep vein thrombosis
pulmonary embolism
pulmonary embolism
Factor Xa Inhibitors
guidelines for drug use
evaluation of the transparency committee
apixaban
administration, oral
insurance, health, reimbursement
adult
factor xa
fibrinolytic agents
treatment outcome
antithrombotic agents
pyrazoles
pyridones
apixaban
venous thrombosis
venous thrombosis
---
https://www.jle.com/fr/revues/medecine/met/e-docs/00/04/99/39/resume.phtml
2014
false
France
French
atrial fibrillation
anticoagulants
journal article
thrombosis
vitamin K
drug interactions
practice guideline
aged
risk assessment
apixaban
edoxaban
pyridines
thiazoles
pyrazoles
pyridones
antithrombins
anticoagulotherapy
Rivaroxaban
Dabigatran
antivitamins K
indenes
4-hydroxycoumarins
---
http://www.cfp.ca/content/60/11/e512.full
2014
false
false
false
Canada
French
journal article
anticoagulants
case reports
drug interactions
stroke
atrial fibrillation
venous thromboembolism
apixaban
food-drug interactions
preoperative care
anticoagulotherapy
Dabigatran
Rivaroxaban
pyrazoles
pyridones
---
http://www.cfp.ca/content/60/11/e504.full
2014
false
false
false
Canada
French
anticoagulants
journal article
antithrombins
apixaban
stroke
atrial fibrillation
venous thromboembolism
comparative study
treatment outcome
case reports
warfarin
anticoagulants
anticoagulotherapy
Rivaroxaban
Dabigatran
pyrazoles
pyridones
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=61902218
2014
false
false
false
France
French
summary of product characteristics
package leaflet
pill, nos
dandruff
apixaban
compression, nos
tablets
seborrhea sicca
apixaban
dandruff
pyrazoles
pyridones
---
http://www.sciencedirect.com/science/article/pii/S0755498214002590
2014
false
false
false
France
French
atrial fibrillation
anticoagulants
administration, oral
anticoagulants
drug interactions
journal article
dabigatran etexilate
rivaroxaban
apixaban
apixaban
edoxaban
warfarin
factor xa
antithrombins
treatment outcome
renal insufficiency
age factors
Direct current cardioversion (procedure)
myocardial infarction
surgical procedures, operative
Factor Xa Inhibitors
anticoagulotherapy
Dabigatran
Rivaroxaban
pyridines
pyrazoles
pyridones
thiazoles
---
https://www.revmed.ch/RMS/2014/RMS-N-416/Nouveaux-anticoagulants-oraux-donnees-pharmacologiques-a-connaitre-pour-la-pratique-clinique
2014
false
false
false
Switzerland
French
journal article
anticoagulants
administration, oral
antithrombins
factor xa
apixaban
thromboembolism
thromboembolism
drug interactions
renal insufficiency
hepatic insufficiency
aged
obesity
anticoagulants
antithrombins
Factor Xa Inhibitors
anticoagulotherapy
Rivaroxaban
Dabigatran
pyrazoles
pyridones
---
http://www.has-sante.fr/portail/jcms/c_2008303/fr/eliquis
http://www.has-sante.fr/portail/jcms/c_1215842/eliquis
2014
false
France
French
stroke
embolism
atrial fibrillation
risk factors
Factor Xa Inhibitors
evaluation of the transparency committee
Contraindications, Procedure
apixaban
administration, oral
insurance, health, reimbursement
venous thromboembolism
adult
factor xa
fibrinolytic agents
treatment outcome
apixaban
apixaban
antithrombotic agents
antithrombotic agents
antithrombotic agents
pyrazoles
pyrazoles
pyrazoles
pyridones
pyridones
pyridones
apixaban
Contraindications, Drug
---
https://www.revmed.ch/RMS/2014/RMS-N-416/Pourquoi-quand-et-comment-doser-les-nouveaux-anticoagulants-oraux
2014
false
false
false
Switzerland
French
journal article
thromboembolism
continuity of patient care
drug monitoring
anticoagulants
administration, oral
rivaroxaban
apixaban
dabigatran etexilate
apixaban
risk factors
blood coagulation tests
kidney failure, chronic
factor xa
antithrombins
Factor Xa Inhibitors
Rivaroxaban
Dabigatran
pyrazoles
pyridones
---
http://www.academie-medecine.fr/rapport-sur-les-anticoagulants-oraux-directs-aod-anterieurement-appeles-nouveaux-anticoagulants-oraux-ou-naco/
http://www.academie-medecine.fr/wp-content/uploads/2014/06/aod2805.pdf
2014
false
false
false
false
France
French
anticoagulants
administration, oral
technical report
anticoagulants
drug interactions
thromboembolism
anticoagulants
pyridines
apixaban
pyrazoles
pyridones
atrial fibrillation
antithrombins
thiazoles
edoxaban
acute coronary syndrome
anticoagulants
vitamin K
orthopedic procedures
anticoagulotherapy
Dabigatran
Dabigatran
Rivaroxaban
---
http://www.has-sante.fr/portail/jcms/c_1700943/fr/point-sur-lutilisation-des-nouveaux-anticoagulants-oraux
2013
false
France
French
anticoagulotherapy
Rivaroxaban
Dabigatran
anticoagulants
administration, oral
dabigatran etexilate
rivaroxaban
apixaban
apixaban
thromboembolism
thromboembolism
product surveillance, postmarketing
hemorrhage
practice guidelines as topic
drug information
pyrazoles
pyridones
---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2013.01679/
2013
false
Switzerland
French
anticoagulotherapy
Rivaroxaban
Dabigatran
dabigatran etexilate
anticoagulants
administration, oral
rivaroxaban
apixaban
apixaban
patient compliance
surgical procedures, operative
venous thromboembolism
atrial fibrillation
thromboembolism
renal insufficiency
perioperative period
hemorrhage
risk management
journal article
pyrazoles
pyridones
---
https://minerva-ebp.be/fr/article/65
2013
false
false
minerva-ebm.be
Belgium
French
venous thromboembolism
treatment outcome
critical appraisal or critical reading
pyrazoles
pyridones
fibrinolytic agents
apixaban
---
https://ansm.sante.fr/uploads/2021/03/12/f6f2d53a601a3f25c5e0eb84dff9dd28.pdf
2013
false
France
French
Factor Xa Inhibitors
anticoagulotherapy
Rivaroxaban
Rivaroxaban
Dabigatran
Dabigatran
anticoagulants
anticoagulants
anticoagulants
administration, oral
hemorrhage
risk
continuity of patient care
thrombin
factor xa
apixaban
examination questions
patient education handout
drug information
rivaroxaban
apixaban
dabigatran etexilate
pyrazoles
pyridones
---
https://minerva-ebp.be/fr/analyses-en-ligne/171
2013
false
false
minerva-ebm.be
Belgium
French
Dutch
recurrence
critical appraisal or critical reading
secondary prevention
apixaban
apixaban
fibrinolytic agents
pyrazoles
pyridones
---
http://www.has-sante.fr/portail/jcms/c_1616483/fr/eliquis
http://www.has-sante.fr/portail/jcms/c_1616000/fr/-eliquis-2-5-mg
2013
false
France
French
guidelines for drug use
antithrombotic agents
antithrombotic agents
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
apixaban
apixaban
apixaban
stroke
embolism
adult
atrial fibrillation
risk factors
fibrinolytic agents
fibrinolytic agents
treatment outcome
clinical trials, phase iii as topic
aged
pyrazoles
pyrazoles
pyridones
pyridones
---
http://www.has-sante.fr/portail/jcms/c_1626282/en/fibrillation-auriculaire-non-valvulaire-quelle-place-pour-les-anticoagulants-oraux-non-antivitamine-k-apixaban-eliquis-dabigatran-pradaxa-et-rivaroxaban-xarelto-fiche-bum
http://www.has-sante.fr/portail/jcms/c_1626266/en/bon-usage-anticoagulants-oraux-non-avk
2013
true
France
French
antivitamins K
anticoagulotherapy
Rivaroxaban
Dabigatran
atrial fibrillation
anticoagulants
administration, oral
apixaban
dabigatran etexilate
apixaban
guidelines for drug use
rivaroxaban
thromboembolism
hemorrhage
anticoagulants
antivitamins K
risk factors
drug interactions
patient compliance
evaluation of the transparency committee
indenes
4-hydroxycoumarins
vitamin K
pyrazoles
pyridones
---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/916
2013
false
false
France
French
stroke
atrial fibrillation
apixaban
warfarin
comparative study
apixaban
warfarin
fibrinolytic agents
anticoagulants
treatment outcome
clinical trials, phase iii as topic
critical appraisal or critical reading
pyrazoles
pyridones
---
http://www.has-sante.fr/portail/jcms/c_1240785/eliquis-apixaban-anticoagulant-oral
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/eliquis_18012012_synthese_ct11097.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-02/eliquis_18012012_avis_ct11097.pdf
2012
France
French
Factor Xa Inhibitors
apixaban
apixaban
administration, oral
insurance, health, reimbursement
factor xa
adult
venous thromboembolism
arthroplasty, replacement, knee
arthroplasty, replacement, hip
postoperative complications
antithrombotic agents
antithrombotic agents
treatment outcome
clinical trials, phase iii as topic
fibrinolytic agents
fibrinolytic agents
product surveillance, postmarketing
pyrazoles
pyrazoles
pyridones
pyridones
apixaban
guidelines for drug use
evaluation of the transparency committee
---
https://www.ema.europa.eu/medicines/human/EPAR/Eliquis
2012
false
United Kingdom
French
English
Factor Xa Inhibitors
syndication feed
pyrazoles
pyrazoles
pyridones
pyridones
apixaban
apixaban
drug approval
treatment outcome
administration, oral
venous thromboembolism
postoperative complications
adult
arthroplasty, replacement, hip
arthroplasty, replacement, knee
factor xa
aged
drug interactions
pregnancy
breast feeding
fertility
fibrinolytic agents
fibrinolytic agents
antithrombotic agents
antithrombotic agents
drug evaluation, preclinical
apixaban
drug evaluation
package leaflet
summary of product characteristics
---
https://minerva-ebp.be/fr/article/183
2012
false
true
false
false
minerva-ebm.be
Belgium
venous thromboembolism
inpatients
enoxaparin
pyrazoles
pyridones
pyrazoles
pyridones
adult
comparative study
critical appraisal or critical reading
apixaban
---
https://minerva-ebp.be/fr/article/236
2011
false
true
false
false
minerva-ebm.be
Belgium
atrial fibrillation
stroke
pyrazoles
pyridones
critical appraisal or critical reading
thromboembolism
apixaban
aspirin
---
